What are the major opportunities in the H1N1 vaccine market? What are the strategies for the H1N1 vaccine market?

For detailed insights on the major opportunities and strategies in the H1N1 vaccine market, Read More

How does the H1N1 vaccine market relate to the overall economy and other similar markets?

For detailed insights on H1N1 vaccine market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the H1N1 vaccine market growth? SWOT analysis of the H1N1 vaccine market.

For detailed insights on the key dynamics influencing the H1N1 vaccine market growth and SWOT analysis of the H1N1 vaccine industry, Read More

H1N1 Vaccine Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

H1N1 Vaccine Market Report 2026

Name: H1N1 Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination ), By End Users (Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

H1N1 Vaccine Market Overview

• H1N1 Vaccine market size has reached to $3.52 billion in 2025

• Expected to grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%

• Growth Driver: Rising Prevalence Of Chronic Diseases Fueling Market Growth Due To Increased Vulnerability To Severe Flu Outcomes

• Market Trend: Needle-Free Nasal vaccines-market" target="_blank">vaccines In The H1N1 Market

• North America was the largest region in 2025.

What Is Covered Under H1N1 Vaccine Market?

H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.

The main product types of H1N1 vaccine are inactivated vaccine, and live attenuated vaccine. The inactivated vaccine market consists of sales of H1N1 vaccine products that are used to prevent disease caused by the influenza H1N1 virus. Inactivated vaccine is a synthetic vaccine with protective immunizing action that contains hemagglutinin (HA) antigens generated from four inactivated influenza viruses, including two different influenza type. A strain and two different influenza type B strains. The various routes of administration include intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination which are used by various end users such as hospitals, clinics, research and diagnostic laboratories, and others.

H1N1 Vaccine Market Global Report 2026 Market Report bar graph

What Is The H1N1 Vaccine Market Size and Share 2026?

The h1n1 vaccine market size has grown strongly in recent years. It will grow from $3.52 billion in 2025 to $3.78 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to past h1n1 pandemic outbreaks, government-led mass immunization campaigns, rising global influenza incidence, public health funding for vaccines, established cold chain infrastructure.

What Is The H1N1 Vaccine Market Growth Forecast?

The h1n1 vaccine market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing pandemic preparedness initiatives, rising elderly population vulnerability, expansion of national immunization schedules, growth in healthcare access in emerging economies, ongoing influenza virus mutation risks. Major trends in the forecast period include expansion of seasonal and pandemic influenza immunization programs, rising use of intranasal vaccines for improved patient compliance, increasing government stockpiling of h1n1 vaccines, growth in pediatric and geriatric vaccination coverage, enhanced focus on rapid vaccine distribution during outbreaks.

Book your 30 minutes free consultation with our research experts

Global H1N1 Vaccine Market Segmentation

1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine

2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination

3) By End Users: Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Inactivated Vaccine: Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine

2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine

What Is The Driver Of The H1N1 Vaccine Market?

The rising prevalence of chronic diseases is expected to propel the growth of the H1N1 vaccine market going forward. Chronic diseases are long-lasting health conditions that typically persist for three months or more and require ongoing medical attention or management, including illnesses such as diabetes, heart disease, and arthritis. Chronic diseases are increasing mainly due to unhealthy lifestyle choices such as poor diet, physical inactivity, and tobacco or alcohol use, which contribute to obesity, high blood pressure, and other long-term health risks. H1N1 vaccines play a crucial role in protecting individuals with chronic diseases by reducing the risk of severe flu-related complications and preventing disease exacerbations, hospitalization, or mortality in vulnerable groups. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the H1N1 vaccine industry.

Key Players In The Global H1N1 Vaccine Market

Major companies operating in the h1n1 vaccine market are Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.

Global H1N1 Vaccine Market Trends and Insights

Major companies in the H1N1 vaccine market are launching new products and solutions, such as a one-of-a-kind needle free nasal vaccine, to sustain their position in the market. A needle-free nasal vaccine is a type of vaccination method that eliminates the use of traditional needles or syringes. Instead, these vaccines are administered through a non-invasive, painless, and needle-free approach, primarily through the nasal route. For instance, in October 2023, Serum Institute, an India-based manufacturer of vaccines in collaboration with Mylab, an India-based diagnostic company, launched Nasovac S4 which is a type of needle free nasal influenza vaccine that focuses on actively immunizing against influenza caused by H1N1 virus and H3N2 virus. The vaccine uses strains from the Type A and Type B virus to produce antibodies against influenza. Nasovac S4 can be used by all individuals above the age of 2 to help stimulate the immune system against influenza.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The H1N1 Vaccine Market?

In July 2023, Sinovac Biotech Ltd., a China-based biopharmaceutical company partnered with Bio Farma to eliminate human diseases. The partnership aims to serve Indonesia's domestic vaccine market as well as international market. The strategic partnership also aims to help Sinovac to introduce future products, including its varicella, influenza, and pneumococcal polysaccharide vaccines, to meet the region’s healthcare needs and further enhance local and national public health efforts. Bio Farma is an Indonesia-based state-owned biopharmaceutical company, operating in various vaccine market.

Regional Insights

North America was the largest region in the H1N1 vaccine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the H1N1 Vaccine Market?

The H1N1 vaccines market consists of sales of TIV (flu shot (injection) and LAIV (nasal spray (mist) of live attenuated influenza vaccine). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the H1N1 Vaccine Market Report 2026?

The h1n1 vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the h1n1 vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

H1N1 Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.78 billion
Revenue Forecast In 2035	$5.05 billion
Growth Rate	CAGR of 7.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Route Of Administration, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation,
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. H1N1 Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global H1N1 Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. H1N1 Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global H1N1 Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Seasonal And Pandemic Influenza Immunization Programs

4.2.2 Rising Use Of Intranasal Vaccines For Improved Patient Compliance

4.2.3 Increasing Government Stockpiling Of H1N1 Vaccines

4.2.4 Growth In Pediatric And Geriatric Vaccination Coverage

4.2.5 Enhanced Focus On Rapid Vaccine Distribution During Outbreaks

5. H1N1 Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Research And Diagnostic Laboratories

5.4 Public Health Agencies

5.5 Vaccination Centers

6. H1N1 Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global H1N1 Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global H1N1 Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global H1N1 Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global H1N1 Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global H1N1 Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global H1N1 Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. H1N1 Vaccine Market Segmentation

9.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Vaccine, Live Attenuated Vaccine

9.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination

9.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users

9.4. Global H1N1 Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine

9.5. Global H1N1 Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine

10. H1N1 Vaccine Market Regional And Country Analysis

10.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific H1N1 Vaccine Market

11.1. Asia-Pacific H1N1 Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China H1N1 Vaccine Market

12.1. China H1N1 Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India H1N1 Vaccine Market

13.1. India H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan H1N1 Vaccine Market

14.1. Japan H1N1 Vaccine Market Overview

14.2. Japan H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia H1N1 Vaccine Market

15.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia H1N1 Vaccine Market

16.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea H1N1 Vaccine Market

17.1. South Korea H1N1 Vaccine Market Overview

17.2. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan H1N1 Vaccine Market

18.1. Taiwan H1N1 Vaccine Market Overview

18.2. Taiwan H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia H1N1 Vaccine Market

19.1. South East Asia H1N1 Vaccine Market Overview

19.2. South East Asia H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe H1N1 Vaccine Market

20.1. Western Europe H1N1 Vaccine Market Overview

20.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK H1N1 Vaccine Market

21.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany H1N1 Vaccine Market

22.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France H1N1 Vaccine Market

23.1. France H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy H1N1 Vaccine Market

24.1. Italy H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain H1N1 Vaccine Market

25.1. Spain H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe H1N1 Vaccine Market

26.1. Eastern Europe H1N1 Vaccine Market Overview

26.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia H1N1 Vaccine Market

27.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America H1N1 Vaccine Market

28.1. North America H1N1 Vaccine Market Overview

28.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA H1N1 Vaccine Market

29.1. USA H1N1 Vaccine Market Overview

29.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada H1N1 Vaccine Market

30.1. Canada H1N1 Vaccine Market Overview

30.2. Canada H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America H1N1 Vaccine Market

31.1. South America H1N1 Vaccine Market Overview

31.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil H1N1 Vaccine Market

32.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East H1N1 Vaccine Market

33.1. Middle East H1N1 Vaccine Market Overview

33.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa H1N1 Vaccine Market

34.1. Africa H1N1 Vaccine Market Overview

34.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. H1N1 Vaccine Market Regulatory and Investment Landscape

36. H1N1 Vaccine Market Competitive Landscape And Company Profiles

36.1. H1N1 Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. H1N1 Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. H1N1 Vaccine Market Company Profiles

36.3.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.3. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Zydus Lifesciences Limited Overview, Products and Services, Strategy and Financial Analysis

37. H1N1 Vaccine Market Other Major And Innovative Companies

Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk

38. Global H1N1 Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The H1N1 Vaccine Market

40. H1N1 Vaccine Market High Potential Countries, Segments and Strategies

40.1 H1N1 Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 H1N1 Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 H1N1 Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global H1N1 Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global H1N1 Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global H1N1 Vaccine Market, Supply Chain Analysis

Table 4: Global H1N1 Vaccine Market, Major Raw Material Providers

Table 5: Global H1N1 Vaccine Market, Major Resource Providers

Table 6: Global H1N1 Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global H1N1 Vaccine Market, Major Distributors And Channel Partners

Table 8: Global H1N1 Vaccine Market, Key Technologies & Future Trends

Table 9: Global H1N1 Vaccine Market, Major Trends

Table 10: Global H1N1 Vaccine Market, Major End Users

Table 11: Global H1N1 Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global H1N1 Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global H1N1 Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global H1N1 Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global H1N1 Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global H1N1 Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global H1N1 Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global H1N1 Vaccine Market - Company Scoring Matrix

Table 96: Sanofi SA Financial Performance

Table 97: GlaxoSmithKline PLC Financial Performance

Table 98: CSL Limited Financial Performance

Table 99: AstraZeneca Inc. Financial Performance

Table 100: Zydus Lifesciences Limited Financial Performance

Table 101: Global H1N1 Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 102: Global H1N1 Vaccine Market, Competitive Dashboard

Table 103: Global H1N1 Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 105: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 106: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

Figure 1: Global H1N1 Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global H1N1 Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global H1N1 Vaccine Market, Supply Chain Analysis

Figure 4: Global H1N1 Vaccine Market, Major Raw Material Providers

Figure 5: Global H1N1 Vaccine Market, Major Resource Providers

Figure 6: Global H1N1 Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global H1N1 Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global H1N1 Vaccine Market, Key Technologies & Future Trends

Figure 9: Global H1N1 Vaccine Market, Major Trends

Figure 10: Global H1N1 Vaccine Market, Major End Users

Figure 11: Global H1N1 Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global H1N1 Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global H1N1 Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global H1N1 Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global H1N1 Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global H1N1 Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global H1N1 Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global H1N1 Vaccine Market - Company Scoring Matrix

Figure 96: Sanofi SA Financial Performance

Figure 97: GlaxoSmithKline PLC Financial Performance

Figure 98: CSL Limited Financial Performance

Figure 99: AstraZeneca Inc. Financial Performance

Figure 100: Zydus Lifesciences Limited Financial Performance

Figure 101: Global H1N1 Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global H1N1 Vaccine Market, Competitive Dashboard

Figure 103: Global H1N1 Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 105: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 106: Global, H1N1 Vaccine Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Swine Vaccines Market Report 2026 - Global Outlook – By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines), By Disease (Viral Infections...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Pediatric Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent ), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease,...

H1N1 Vaccine Market Report 2026 - Global Outlook – By Product Type (Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination...

Frequently Asked Questions

How big is the H1N1 Vaccine Market?

The H1N1 Vaccine market was valued at $3.52 billion in 2025, increased to $3.78 billion in 2026, and is projected to reach $5.05 billion by 2030.

What is the H1N1 Vaccine market growth?

The global H1N1 Vaccine market is expected to grow at a CAGR of 7.5% from 2026 to 2035 to reach $5.05 billion by 2035.

Who are the key players in H1N1 Vaccine market?

Some Key Players in the H1N1 Vaccine market Include, Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc. .

What is the anticipated growth trend for the H1N1 Vaccine market?

Major trend in this market includes: Needle-Free Nasal Vaccines In The H1N1 Market. For further insights on this market. request a sample here

Which region has the most growth potential in the H1N1 Vaccine market?

North America was the largest region in the H1N1 vaccine market in 2025. The regions covered in the h1n1 vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.